The Neurobiology and Neuropharmacology of Alzheimer's Disease. The ASPET - Ray Fuller Symposium. New Orleans, LA, USA, April 19-20, 2002.
Scriabine
A
A
D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001569:Benzodiazepines; D001581:Benzothiadiazines / Q000627:therapeutic use; D006801:Humans; D009446:Neurobiology; D009480:Neuropharmacology; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D001581:Benzothiadiazines; D018696:Neuroprotective Agents; D010078:Oxazines; C061950:GYKI 52466; D001569:Benzodiazepines; C414782:2H,3H,6aH-pyrrolidino(2'',1''-3',2')1,3-oxazino(6',5'-5,4)benzo(e)1, 4-dioxan-10-one; C004639:cyclothiazide